| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.87B | 3.65B | 3.15B | 2.92B | 2.57B | 2.40B |
| Gross Profit | 1.74B | 3.34B | 2.58B | 2.42B | 2.16B | 2.06B |
| EBITDA | 2.08B | 2.58B | 2.11B | 2.07B | 1.87B | 1.80B |
| Net Income | 1.10B | 1.06B | 885.40M | 857.00M | 789.40M | 785.50M |
Balance Sheet | ||||||
| Total Assets | 28.08B | 27.19B | 23.47B | 22.83B | 22.39B | 20.70B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 2.74B | 1.74B | 2.41B | 2.55B | 3.31B |
| Total Debt | 14.75B | 13.86B | 12.98B | 11.76B | 12.42B | 12.34B |
| Total Liabilities | 20.55B | 19.64B | 17.10B | 16.63B | 17.60B | 16.28B |
| Stockholders Equity | 7.51B | 7.52B | 6.32B | 5.15B | 4.68B | 4.37B |
Cash Flow | ||||||
| Free Cash Flow | -1.37B | -1.16B | -963.90M | 831.40M | -511.90M | -245.20M |
| Operating Cash Flow | 695.70M | 1.47B | 1.08B | 2.32B | 832.30M | 941.40M |
| Investing Cash Flow | -2.40B | -2.40B | -2.33B | -1.86B | -863.30M | -1.39B |
| Financing Cash Flow | 1.07B | 1.87B | 464.30M | 92.50M | -1.05B | 2.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €20.73B | 16.37 | 14.70% | 4.41% | 10.18% | 8.43% | |
63 Neutral | €100.20B | 22.77 | 23.22% | 5.05% | -3.10% | 26.28% | |
63 Neutral | €10.73B | 4.81 | ― | 4.05% | -3.34% | 8.88% | |
61 Neutral | €3.36B | 23.79 | 9.06% | 5.06% | 10.48% | 9.06% | |
56 Neutral | €6.10B | 8.70 | 13.30% | 3.76% | 15.98% | 19.01% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |